However, ketogenic diet may increase CRP and liver enzyme, and therefore, longer-term studies are needed to confirm its efficacy and safety, and to recommend its use only in selected patients and under strict medical supervision [86]
Retatrutide delivers 24.2% average weight loss over 48 weeks through triple-receptor activation (GLP-1, GIP, and glucagon), while KLOW provides 80mg of synergistic healing compounds
Its effectiveness as a weight loss drug is attributed to its appetite suppression through hypothalamic stimulation, increasing feelings of satiety
Moreover, the stepwise administration of amylin and GLP-1R analogs was able to break the plateau normally observed with individual pharmacotherapies, even when combined from the beginning of treatment, thus supporting the hypothesis that a stepwise-introduction of a combinatorial pharmacological approach at treating obesity is more effective in achieving a sustained and long-lasting degree of weight loss